Copyright
©The Author(s) 2019.
World J Clin Cases. Jan 26, 2019; 7(2): 171-190
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.171
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.171
Ref. | Country | Cancer type | Stage | Control | Number of Control | Number of patients | Sample | Isolation method of exosome | Marker | Detection method | Cut-off | TP | TN | FP | FN |
Sun et al[35] | China | Colorectal | All | Healthy | 32 | 92 | Plasma | UC | CPNE3 | ELISA | 0.143 pg/μg exosome | 62 | 27 | 5 | 30 |
Ogata-Kawata et al[36] | Japan | Colorectal | All | Healthy | 11 | 88 | Serum | UC | miR-1246 | qRT-PCR | 1.45 | 84 | 10 | 4 | 1 |
miR-23a | 0.3100 | 81 | 11 | 7 | 0 | ||||||||||
miR-21 | 1.08 | 54 | 10 | 34 | 1 | ||||||||||
miR-150 | 0.08 | 49 | 11 | 39 | 0 | ||||||||||
let-7a | 0.9 | 44 | 10 | 44 | 1 | ||||||||||
miR-223 | 1.72 | 41 | 10 | 47 | 1 | ||||||||||
miR-1224-5p | 0.5 | 28 | 11 | 60 | 0 | ||||||||||
miR-1229 | 0.06 | 20 | 11 | 68 | 0 | ||||||||||
Liu et al[37] | China | Colorectal | All | Healthy and benign | 320 | 148 | Serum | ExoQuick | CRNDE-h | qRT-PCR | 0.02 | 104 | 302 | 18 | 44 |
Uratani et al[38] | Japan | Colorectal | NR | Healthy | 47 | 26 | Serum | ExoQuick | miR-21 | qRT-PCR | Youden index | 18 | 38 | 9 | 8 |
Lin et al[39] | China | Gastric | All | Healthy | 60 | 51 | Plasma | UC | lncUEGC1 | qRT-PCR | NR | 45 | 50 | 10 | 6 |
lncUEGC2 | NR | 46 | 34 | 26 | 17 | ||||||||||
Zhao et al[40] | China | Gastric | All | Healthy | 120 | 126 | Serum | NR | HOTTIP | qRT-PCR | 1.72 | 88 | 102 | 18 | 38 |
Pang et al[41] | China | Gastric | All | Healthy | 37 | 40 | Serum | ExoQuick | ZFAS1 | qRT-PCR | NR | 32 | 28 | 9 | 8 |
Yang et al[42] | China | Gastric | All | Healthy | 80 | 80 | Serum | ExoQuick | miR-423-5p | qRT-PCR | NR | 65 | 46 | 34 | 15 |
Goto et al[43] | Japan | Pancreatic | All | Healthy and advanced pancreatic cancer | 22 | 23 | Serum | ExoQuick | miR-191 | qRT-PCR | Distance = (1-sensitivity)2 + (1-specificity)2 in ROC curve | 18 | 17 | 5 | 5 |
miR-21 | 20 | 18 | 4 | 3 | |||||||||||
miR-451a | 16 | 18 | 4 | 7 | |||||||||||
Melo et al[44] | Germany | Pancreatic | All | Healthy | 100 | 190 | Serum | UC | GPC1 | Flow cytometry | Youden index | 190 | 100 | 0 | 0 |
Que et al[45] | China | Pancreatic | All | Non-PDAC | 27 | 22 | Serum | UC | miR-17-5p | qRT-PCR | 6.826 | 20 | 20 | 7 | 2 |
miR-21 | 7.693 | 18 | 26 | 1 | 4 | ||||||||||
Machida et al[46] | Japan | Pancreatobiliary tract | II-IV | Healthy | 13 | 12 | Saliva | Total exosome isolation kit | miR-1246 | qRT-PCR | 13.77 | 8 | 13 | 0 | 4 |
miR-4644 | -5.205 | 9 | 10 | 3 | 3 | ||||||||||
Xu et al[47] | China | Liver | All | Chronic hepatitis B | 68 | 88 | Serum | Total exosome isolation kit | hnRNPH1 | qRT-PCR | 0.67 | 75 | 52 | 16 | 13 |
Sun et al[48] | China | Liver | All | Healthy | 56 | 56 | Serum | Total exosome isolation kit | LINC00161 | qRT-PCR | NR | 42 | 41 | 15 | 14 |
Xu et al[49] | China | Liver | All | Chronic hepatitis B | 96 | 60 | Serum | Total exosome isolation kit | ENSG00000258332.1 | qRT-PCR | 1.345 | 43 | 80 | 16 | 17 |
60 | 55 | ENSG00000258332.1 | 1.366 | 40 | 48 | 12 | 15 | ||||||||
96 | 60 | LINC00635 | 1.69 | 46 | 75 | 21 | 14 | ||||||||
60 | 55 | LINC00635 | 1.532 | 44 | 45 | 15 | 11 | ||||||||
Goldvaser et al[50] | Israel | Pan-cancer (not include liver) | Healthy | 45 | 98 | Serum | Total exosome isolation kit | hTERT | qRT-PCR | NR | 61 | 45 | 0 | 37 | |
Liver | NR | Healthy | 45 | 35 | NR | 21 | 45 | 0 | 14 | ||||||
Zhang et al[51] | China | Lung | All | Healthy | 30 | 77 | Serum | ExoQuick | MALAT-1 | qRT-PCR | NR | 62 | 21 | 9 | 15 |
Sun et al[52] | China | Lung | All | Healthy | 15 | 15 | Plasma | UC | 14-3-3ζ | ELISA | 9 | 12 | 3 | 6 | |
Li et al[53] | NR | Ovarian | Benign | 21 | 50 | Serum | UC | ephrinA2 | ELISA | 20.4 ng/L | 44 | 17 | 4 | 6 | |
Meng et al[54] | NR | Ovarian | All | Benign | 20 | 163 | Serum | Total exosome isolation kit | miR-200a | PCR+ qRT-PCR | Youden index | 135 | 18 | 2 | 28 |
miR-200b | 86 | 20 | 0 | 77 | |||||||||||
miR-200c | 51 | 20 | 0 | 112 | |||||||||||
Pan et al[55] | Germany | Ovarian | All | Healthy | 29 | 106 | Plasma | ExoQuick | miR-21 | PCR+ qRT-PCR | Youden index | 65 | 24 | 5 | 41 |
miR-100 | 66 | 21 | 8 | 40 | |||||||||||
miR-200b | 68 | 25 | 4 | 38 | |||||||||||
miR-320 | 59 | 20 | 9 | 47 | |||||||||||
Bryzgunova et al[56] | Russia | Prostate | All | Healthy | 20 | 14 | Urine | UC | miR-125 | qRT-PCR | NR | 12 | 13 | 7 | 2 |
miR-19b | NR | 11 | 19 | 1 | 3 | ||||||||||
Wang et al[57] | China | Prostate | II-IV | Healthy | 30 | 34 | Plasma | Total exosome isolation kit | SAP30L-AS1 | qRT-PCR | NR | 21 | 25 | 5 | 13 |
SChLAP1 | NR | 30 | 23 | 7 | 4 | ||||||||||
Øverbye et al[58] | NR | Prostate | All | Healthy | 15 | 16 | Urine | UC | ADIRF | Mass spectrometry | Youden index | 12 | 16 | 0 | 3 |
TMEM256 | 14 | 16 | 0 | 1 | |||||||||||
Işın et al[59] | NR | Prostate | All | BPH | 49 | 30 | Urine | Urine Exosome RNA Isolation Kit | LincRNA-p21 | qRT-PCR | 0.181 | 20 | 31 | 18 | 10 |
Wang et al[60] | China | Laryngeal | All | Vocal cord polyps | 49 | 52 | Serum | ExoQuick | miR-21 | qRT-PCR | 0.043 | 36 | 40 | 9 | 16 |
HOTAIR | 0.032 | 48 | 28 | 21 | 4 | ||||||||||
Alegre et al[61] | NR | Melanoma | NR | Healthy | 25 | 53 | Serum | ExoQuick | exo-MIA | ELISA | 1.4 μg/L | 42 | 20 | 5 | 11 |
exo-S100B | ELISA | 0.015 μg/L | 42 | 20 | 5 | 11 | |||||||||
Manterola et al[62] | France | GBM | NR | Healthy | 30 | 50 | Serum | ExoQuick | RNU6 | qRT-PCR | 0.372 | 33 | 20 | 10 | 17 |
Chen et al[63] | Taiwan | Bladder | All | hernia | 81 | 140 | Urine | UC | TACSTD2 | ELISA | 2.47 ng/mL | 103 | 62 | 19 | 37 |
Ge et al[64] | China | Cholangiocarcinoma | All | Biliary obstruction | 56 | 35 | Bile | UC | ENST00000588480.1 | qRT-PCR | NR | 22 | 41 | 15 | 13 |
- Citation: Wong CH, Chen YC. Clinical significance of exosomes as potential biomarkers in cancer. World J Clin Cases 2019; 7(2): 171-190
- URL: https://www.wjgnet.com/2307-8960/full/v7/i2/171.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i2.171